Department of Surgery, Kuma Hospital, 8-2-35, Shimoyamate-dori, Chuo-ku, Kobe City, 650-0011, Japan.
World J Surg. 2010 Jun;34(6):1285-90. doi: 10.1007/s00268-009-0356-0.
BACKGROUND: The extent of surgery for papillary carcinoma significantly differs between western countries and Japan. Almost routine total thyroidectomy with radioiodine ablation therapy has been performed in western countries, whereas limited thyroidectomy has been adopted in Japan, especially for low-risk cases. In this study, the prognosis of patients with solitary papillary carcinoma measuring 2 cm or less without massive extrathyroid extension, clinically apparent lymph node metastasis or distant metastasis at diagnosis (T1N0M0 in the UICC TNM classification) was investigated to elucidate the appropriate extent of surgery for these patients. METHODS: We investigated the prognosis of 2,638 patients with solitary T1N0M0 papillary carcinoma who underwent initial surgery between 1987 and 2004. Total or near total thyroidectomy was performed for 1,037 patients and the remaining 1,601 patients underwent more limited thyroidectomy. Elective central node dissection was performed for 2,511 patients, accounting for 96%, and 1,545 (59%) also underwent prophylactic lateral node dissection. Radioiodine ablation therapy was performed only for three patients. RESULTS: The 10-year disease-free survival (DFS) rate of our series was 97%. To date, recurrence was observed in 62 patients (2%) and 41 showed recurrence to the regional lymph nodes. Seventeen of 1,601 patients who received limited thyroidectomy (1%) showed recurrence to the remnant thyroid. Pathological nodal-positive patients showed a worse DFS, but the 10-year DFS rate was still high at 96%. Patients with total or near total thyroidectomy had a better DFS, but the difference disappeared if recurrence to the remnant thyroid was excluded. A number needed to treat (NNT) for total or near total thyroidectomy over hemithyroidectomy was 83 to prevent 1 recurrence. CONCLUSIONS: These findings suggest that solitary T1N0M0 patients have an excellent prognosis when they undergo thyroidectomy and elective lymph node dissection without radioiodine therapy. Regarding the extent of thyroidectomy, hemithyroidectomy is adequate for these patients, if a 1% risk of recurrence to the remnant thyroid is accepted.
背景:西方国家和日本在甲状腺乳头状癌的手术范围上存在显著差异。在西方国家,几乎常规进行全甲状腺切除术和放射性碘消融治疗,而在日本则采用有限的甲状腺切除术,特别是对于低危病例。在这项研究中,我们研究了诊断时无大量甲状腺外侵犯、临床明显淋巴结转移或远处转移(UICC TNM 分类中的 T1N0M0)的 2cm 或以下单发甲状腺乳头状癌患者的预后,以阐明这些患者的适当手术范围。
方法:我们调查了 1987 年至 2004 年间接受初始手术的 2638 例单发 T1N0M0 甲状腺乳头状癌患者的预后。1037 例患者接受了全甲状腺或近全甲状腺切除术,其余 1601 例患者接受了更有限的甲状腺切除术。2511 例患者选择性进行中央淋巴结清扫术,占 96%,其中 1545 例(59%)还预防性进行侧方淋巴结清扫术。仅对 3 例患者进行放射性碘消融治疗。
结果:本研究系列的 10 年无病生存率(DFS)为 97%。迄今为止,62 例(2%)患者出现复发,41 例复发至区域淋巴结。在接受有限甲状腺切除术的 1601 例患者中,有 17 例(1%)出现残余甲状腺复发。淋巴结阳性患者的 DFS 较差,但 10 年 DFS 率仍高达 96%。全甲状腺或近全甲状腺切除术患者的 DFS 更好,但如果排除残余甲状腺复发,则差异消失。全甲状腺或近全甲状腺切除术相对于半甲状腺切除术预防 1 例复发的治疗需要数(NNT)为 83。
结论:这些发现表明,对于接受甲状腺切除术和选择性淋巴结清扫术而不进行放射性碘治疗的单发 T1N0M0 患者,预后良好。对于甲状腺切除术的范围,如果接受残余甲状腺复发 1%的风险,半甲状腺切除术对这些患者是足够的。
Schweiz Med Wochenschr. 1995-11-18
JAMA Otolaryngol Head Neck Surg. 2025-2-1
Acta Endocrinol (Buchar). 2023
World J Surg. 2004-11
J Clin Endocrinol Metab. 2001-4